Literature DB >> 8355744

Prevalence and magnitude of perinatal substance exposures in California.

W A Vega1, B Kolody, J Hwang, A Noble.   

Abstract

BACKGROUND: Perinatal substance exposure has been linked to many neonatal and obstetrical complications. There have been few population-based epidemiologic studies to identify the prevalence and demographic profiles associated with drugs, alcohol, and smoking during pregnancy.
METHODS: We studied a fully probabilistic stratified-cluster sample to estimate the prevalence of perinatal substance exposures in California in 1992. Urine samples from 29,494 women presenting for delivery in 202 hospitals were coded and screened for toxins; the results of toxicology screening were later linked by code number to the subjects' demographic variables and their reported use of tobacco and prescribed drugs. Urinary toxicologic tests provide conservative estimates because they can detect only very recent substance use.
RESULTS: The weighted prevalence for perinatal substance exposure was 5.16 percent for the use of one or more drugs, 6.72 percent for alcohol (analyzed independently), and 8.82 percent for self-reported smoking. The percentage of women testing positive for any drug, including alcohol, was 11.35 percent. Estimates for racial and ethnic groups varied widely. Black women had the highest prevalence of total drug use (14.22 percent), alcohol use (11.58 percent), cocaine use (7.79 percent), and tobacco use (20.12 percent). Most drug exposures occurred among white non-Hispanic and Hispanic women. White non-Hispanic women had the second highest prevalence rate for the use of one or more drugs (6.79 percent) and self-reported tobacco use (14.82 percent). Hispanic women had the second highest prevalence rate for alcohol (6.87 percent).
CONCLUSIONS: In California in 1992, there were 67,361 estimated perinatal exposures to one or more drugs, including alcohol, and 52,346 self-reported exposures to tobacco. These findings have clinical and public health implications.

Entities:  

Mesh:

Year:  1993        PMID: 8355744     DOI: 10.1056/NEJM199309163291207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  28 in total

1.  Changes in prenatal care timing and low birth weight by race and socioeconomic status: implications for the Medicaid expansions for pregnant women.

Authors:  L Dubay; T Joyce; R Kaestner; G M Kenney
Journal:  Health Serv Res       Date:  2001-06       Impact factor: 3.402

2.  Substance use during pregnancy: time for policy to catch up with research.

Authors:  Barry M Lester; Lynne Andreozzi; Lindsey Appiah
Journal:  Harm Reduct J       Date:  2004-04-20

3.  Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy.

Authors:  Krista M Perreira; Kalena E Cortes
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

4.  Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.

Authors:  Chee M Ng; Erin Dombrowsky; Hopi Lin; Michelle E Erlich; David E Moody; Jeffrey S Barrett; Walter K Kraft
Journal:  Pharmacotherapy       Date:  2015-07-14       Impact factor: 4.705

5.  Neighborhood Effects on Youth Substance Use in a Southwestern City.

Authors:  Stephen Kulis; Flavio Francisco Marsiglia; Diane Sicotte; Tanya Nieri
Journal:  Sociol Perspect       Date:  2007

6.  Selective neuronal toxicity of cocaine in embryonic mouse brain cocultures.

Authors:  M C Nassogne; P Evrard; P J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Co-occurring alcohol, drug, and other psychiatric disorders among Mexican-origin people in the United States.

Authors:  William A Vega; William M Sribney; Ijeoma Achara-Abrahams
Journal:  Am J Public Health       Date:  2003-07       Impact factor: 9.308

8.  Inconsistent report of pre-pregnancy-recognition alcohol use by Latinas.

Authors:  Suzanne C Hughes; Christina D Chambers; Nada Kassem; Dennis R Wahlgren; Sarah Larson; Edward P Riley; Melbourne F Hovell
Journal:  Matern Child Health J       Date:  2008-09-23

9.  Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL).

Authors:  Chris Derauf; Linda L LaGasse; Lynne M Smith; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry M Lester
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

10.  Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.

Authors:  Walter K Kraft; Eric Gibson; Kevin Dysart; Vidula S Damle; Jennifer L Larusso; Jay S Greenspan; David E Moody; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Pediatrics       Date:  2008-08-11       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.